United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)” report has been added to ResearchAndMarkets.com’s offering.


The U.S. medical diagnostics market is anticipated to reach US$43.89 billion in 2028, witnessing growth at a CAGR of 4.62%, over the period 2024-2028

The factors such as increasing geriatric population, growing burden of chronic diseases, escalating penetration of electronic health record (EHR) systems, hike in healthcare expenditure and expanding urbanization would drive the growth of the market.

However, the market growth would be challenged by dearth of trained laboratory technicians, high cost of high end molecular diagnostics and in vitro diagnostics devices and challenging premarket approval (PMA) & IVD labelling requirements. A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.

The U.S. medical diagnostics market has been segmented on the basis of type, product type and end-users. In terms of type, the market can be bifurcated into in-vitro diagnostics and in-vivo diagnostics. The U.S. in-vitro diagnostics market is further divided on the basis of product type and application. Depending on the product type, the U.S. medical diagnostics market can be segmented into reagents, instruments and software & services. Whereas, the market can be split into hospitals, diagnostic centers and Physician Office Labs (POLs) & others, on the basis of end-users.

The fastest growing regional market was Southern U.S., owing to the rising susceptibility of the population to various chronic and infectious diseases, growing adoption of automation in reference laboratories and hospitals, increasing patient awareness about personalized medicine and shifting preference towards point-of-care (POC) testing.

Scope of the report

The report provides a comprehensive analysis of the U.S. medical diagnostics market segmented on the basis of type, product type, end users and region.

The major regional and country markets (Southern, Mid-Western, Western and North Eastern U.S.) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., and BioMerieux SA) are also presented in detail.

Key Target Audience

Diagnostic Service Providers

Diagnostic Products Manufacturers and Distributors of IVD Products

Hospitals, Public Labs, Diagnostic Centers and Other Stakeholders

Organizations, Forums and Alliances related to Medical Diagnostics

Healthcare and Medical Consultants

Government Bodies & Regulating Authorities

Key Attributes:

Report Attribute
Details

No. of Pages
73

Forecast Period
2024 – 2028

Estimated Market Value (USD) in 2024
$36.63 Billion

Forecasted Market Value (USD) by 2028
$43.89 Billion

Compound Annual Growth Rate
4.6%

Regions Covered
United States

 

 

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Types of Diagnostics

1.3 General Components of a Diagnostic Procedure

1.4 Anatomy of a Diagnostic Test

1.5 Categories of Diagnostic Tests

1.6 Major Roles of Diagnostic Testing

1.7 Sources of Medical Information for Diagnosis

1.8 Common Types of Diagnostic Tools

2. Impact of COVID-19

2.1 Demand Surge for Medical Diagnostics

2.2 Growth in Government Spending on Healthcare

2.3 Surging Adoption of Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)

3. The U.S. Market Analysis

3.1 The U.S. Medical Diagnostics Market by Value

3.2 The U.S. Medical Diagnostics Market Forecast by Value

3.3 The U.S. Medical Diagnostics Market by Type

3.3.1 The U.S. In-Vitro Diagnostics Market by Value

3.3.2 The U.S. In-Vitro Diagnostics Market Forecast by Value

3.3.3 The U.S. In-Vitro Diagnostics Market by Product Type

3.3.4 The U.S. In-Vitro Diagnostics Product Type Market by Value

3.3.5 The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value

3.3.6 The U.S. In-Vitro Diagnostics Market by Application

3.3.7 The U.S. In-Vitro Diagnostics Application Market Forecast by Value

3.3.8 The U.S. In-Vivo Diagnostics Market by Value

3.3.9 The U.S. In-Vivo Diagnostics Market Forecast by Value

3.4 The U.S. Medical Diagnostics Market by Product Type

3.4.1 The U.S. Medical Diagnostics Product Type Market by Value

3.4.2 The U.S. Medical Diagnostics Product Type Market Forecast by Value

3.5 The U.S. Medical Diagnostics Market by End-Users

3.5.1 The U.S. Medical Diagnostics End-User Market by Value

3.5.2 The U.S. Medical Diagnostics End-User Market Forecast by Value

3.6 The U.S. Medical Diagnostics Market by Region

4. Regional Market Analysis

4.1 Southern U.S.

4.1.1 Southern U.S. Medical Diagnostics Market Forecast by Value

4.2 Mid-Western U.S.

4.2.1 Mid-Western U.S. Medical Diagnostics Market Forecast by Value

4.3 Western U.S.

4.3.1 Western U.S. Medical Diagnostics Market Forecast by Value

4.4 North Eastern U.S.

4.4.1 North Eastern U.S. Medical Diagnostics Market Forecast by Value

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Geriatric Population

5.1.2 Growing Burden of Chronic Diseases

5.1.3 Escalating Penetration of Electronic Health Record (EHR) Systems

5.1.4 Hike in Healthcare Expenditure

5.1.5 Expanding Urbanization

5.2 Key Trends and Developments

5.2.1 Surging Adoption of Healthcare-related Devices Like Wearables

5.2.2 Emergence of Various Pandemic Diseases

5.2.3 Rising Integration with Artificial Intelligence

5.2.4 Growing Awareness on Personalized Medicine

5.3 Challenges

5.3.1 Dearth of Trained Laboratory Technicians

5.3.2 High Cost of High-end Molecular Diagnostics & In-Vitro Diagnostics Devices

5.3.3 Challenging Premarket Approval (PMA) & IVD Labelling Requirements

6. Company Profiles

6.1 Roche Holding AG

6.2 Abbott Laboratories

6.3 Danaher Corporation

6.4 Becton, Dickinson and Company

6.5 Quest Diagnostics Inc.

6.6 BioMerieux SA

For more information about this report visit https://www.researchandmarkets.com/r/ktnk8r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.